Alessia Landi
About Alessia Landi
Alessia Landi is a Senior Associate in Regulatory Affairs at BeiGene, with a background in technical regulatory affairs and a PhD in Cell Biology from the University of Freiburg.
Title
Alessia Landi is a Senior Associate in Regulatory Affairs at BeiGene. In this role, she contributes to regulatory submissions and has been involved in the preparation and review of critical documents, including INDs, NDAs, and MAAs. Her expertise includes European regulatory requirements for pharmaceuticals and engaging in regulatory strategy development for new drug applications.
Professional Background
Alessia Landi has a diverse professional background across several prestigious organizations. She was an intern in Technical Regulatory Affairs at Roche from 2019 to 2020. Before Roche, she pursued her PhD as a graduate student at the University of Freiburg from 2015 to 2019. Prior to her PhD, she worked at the Institute for Research in Biomedicine in Bellinzona from 2013 to 2015. Alessia also held research roles at Eli Lilly and Company, including as a Contractor Researcher in the UK in 2013 and as a recipient of the Leonardo da Vinci fellowship from 2012 to 2013.
Education and Expertise
Alessia Landi holds a PhD (Dr. rer. nat) in Cell Biology from The University of Freiburg, completed in 2020. Her doctoral studies spanned five years, from 2015 to 2020. She earned her Master's degree in Chemistry and Pharmaceutical Technology from the University of Pisa, where she studied from 2006 to 2012. Her academic background provides a solid foundation for her regulatory affairs expertise, particularly in European regulatory requirements and oncology product submissions.
Experience in Regulatory Affairs
In her current role at BeiGene, Alessia Landi focuses on regulatory affairs for oncology products. She has considerable experience in engaging cross-functional teams to support drug development and approval processes. Her work involves preparing and reviewing key regulatory documents like INDs, NDAs, and MAAs. Moreover, Alessia's expertise extends to developing regulatory strategies for new drug applications, leveraging her comprehensive understanding of European regulatory requirements.
Contributions to Oncology Product Submissions
Alessia Landi has made significant contributions to the regulatory submissions for oncology products at BeiGene. Her work ensures compliance with regulatory standards, aiding in the timely approval and launch of new oncology treatments. By participating in regulatory strategy development and cross-functional teams, she supports the drug development process from inception to approval.